These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6256875

  • 21. [One year fenofibrate treatment of type II primary hyperlipidaemia. Effects on lipoproteins and biological tolerance (author's transl)].
    Drouin P, Méjean L, Lambert D, Wülfert E, Debry G.
    Nouv Presse Med; 1980 Dec 22; 9(49):3753-7. PubMed ID: 7208342
    [Abstract] [Full Text] [Related]

  • 22. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G, Fellin R, Calabrò A, Baiocchi MR, Rossi A, Lenzi S, Descovich GC, Delmonte G, Gaddi A, Ventura A.
    Monogr Atheroscler; 1986 Dec 22; 14():215-21. PubMed ID: 3526129
    [No Abstract] [Full Text] [Related]

  • 23. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Double-blind study on the activity of plafibride in the treatment of type IV hyperlipoproteinemia.
    Ferreira IJ, del Rio A, González-Viejo N, Vicens B.
    Arzneimittelforschung; 1981 Apr 22; 31(10a):1859-62. PubMed ID: 7032533
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of gemfibrozil on serum lipid levels.
    Dahlén G, Gillnäs T, Børresen AL, Berg K, Ericson C.
    Artery; 1980 Apr 22; 7(3):224-31. PubMed ID: 7008748
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of the effect of hypolipemic drugs in atherosclerosis].
    Beaumont JL.
    Nouv Presse Med; 1980 Oct 30; 9(40):2945-6. PubMed ID: 7443427
    [No Abstract] [Full Text] [Related]

  • 33. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G, Fragiacomo C, Weidmann P, Bachmann C.
    Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
    Colombo L, Monarca A, Goldberg D, Zanetta R.
    Clin Ter; 1979 Oct 31; 91(2):155-71. PubMed ID: 540479
    [No Abstract] [Full Text] [Related]

  • 37. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G, Di Garbo V, Abruzzese G, Campisi D, De Simone R, Raneli G, Licata G.
    Int Angiol; 2006 Mar 31; 25(1):26-34. PubMed ID: 16520721
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinical experience with bezafibrate.
    Schubotz R, Schneider J, Hausmann L, Mühlfellner G, Mühlfellner O, Kaffarnik H.
    Artery; 1980 Mar 31; 8(6):553-9. PubMed ID: 7259534
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.